- Clone
- QA20A70 (See other available formats)
- Regulatory Status
- RUO
- Other Names
- LTB4R, BLT1, LTBR1, LTB4R1, Leukotriene B4 Receptor
- Isotype
- Mouse IgG2a, κ
- Ave. Rating
- Submit a Review
- Product Citations
- publications
Cat # | Size | Price | Save |
---|---|---|---|
383609 | 25 tests | ¥42,460 | |
383610 | 100 tests | ¥87,120 |
Leukotriene B4 receptor (BLTR or LTB4R-1), is a G protein-coupled receptor. It functions as a leukocyte chemoattractant. It activates the G1 family of the G proteins to mediate chemotaxis and it also uses G proteins to mediate cytotoxic activities. BLTR plays an important role in the recruitment and retention of leukocytes, primarily eosinophils.
Product DetailsProduct Details
- Verified Reactivity
- Human
- Antibody Type
- Recombinant
- Host Species
- Mouse
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
- Preparation
- The antibody was purified by affinity chromatography and conjugated with PerCP/Cyanine5.5 under optimal conditions.
- Concentration
- Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
-
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µL per million cells in 100 µL staining volume or 5 µL per 100 µL of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.
* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm. - Excitation Laser
-
Blue Laser (488 nm)
- RRID
-
AB_3083381 (BioLegend Cat. No. 383609)
AB_3083381 (BioLegend Cat. No. 383610)
Antigen Details
- Structure
- G protein-coupled receptor
- Distribution
-
Granulocytes, Monocytes, Dendritic cells
- Function
- Leukocyte chemoattractant
- Ligand/Receptor
- Leukotriene B4
- Cell Type
- Basophils, Epithelial cells, Granulocytes, Leukocytes, Mast cells, Monocytes, Neutrophils
- Biology Area
- Cell Biology, Immunology
- Molecular Family
- GPCR, Innate Immune Signaling
- Antigen References
-
- Yokomizo Y, et al. 1997. Nature. 387:620-4
- Lundeen KA, et al. 2006. J Immunol. 177:3439-47
- Gene ID
- 1241 View all products for this Gene ID
- UniProt
- View information about BLTR on UniProt.org
Related FAQs
- How stable is PerCP/Cyanine5.5 tandem as compared to PerCP alone?
-
PerCP/Cyanine5.5 is quite photostable and also better than PerCP alone in withstanding fixation.
Other Formats
View All BLTR Reagents Request Custom ConjugationDescription | Clone | Applications |
---|---|---|
Purified anti-human BLTR Recombinant Antibody | QA20A70 | FC |
PE anti-human BLTR Recombinant Antibody | QA20A70 | FC |
APC anti-human BLTR Recombinant Antibody | QA20A70 | FC |
FITC anti-human BLTR Recombinant Antibody | QA20A70 | FC |
PerCP/Cyanine5.5 anti-human BLTR Recombinant Antibody | QA20A70 | FC |
Compare Data Across All Formats
This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.
-
Purified anti-human BLTR Recombinant Antibody
Human peripheral blood granulocytes were stained with purifi... -
PE anti-human BLTR Recombinant Antibody
Human peripheral blood granulocytes were stained with anti-h... -
APC anti-human BLTR Recombinant Antibody
Human peripheral blood granulocytes were stained with anti-h... -
FITC anti-human BLTR Recombinant Antibody
Human peripheral blood granulocytes were stained with anti-h... -
PerCP/Cyanine5.5 anti-human BLTR Recombinant Antibody
Human peripheral blood granulocytes were stained with anti-h...
Follow Us